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Abstract The role of the evolutionarily conserved residue Pro-
53 in Proteus mirabilis glutathione transferase B1-1 has been
examined by replacing it with a serine residue using site-directed
mutagenesis. The effect of the replacement on the activity,
thermal stability and antibiotic binding capacity of the enzyme
was examined. The results presented support the view that Pro-
53 participates in the maintenance of the proper conformation of
the enzyme fold rather than playing a direct role in the catalytic
reaction. Furthermore, this residue appears to be an important
determinant of the antibiotic binding to the enzyme. Experiments
with wild type and mutated enzymes provide evidence that
glutathione transferases may play an important role in antibiotic
resistance exhibited by bacteria.
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1. Introduction
Cytosolic glutathione transferases (GSTs; EC 2.5.1.18) are
a family of dimeric multi-functional proteins which catalyse
the conjugation of glutathione (GSH) to a large variety of
endogenous and exogenous electrophilic molecules [1^3].
GSTs are widely distributed in nature: they are found in all
eukaryotes and many prokaryotes [1^9]. Cytosolic GSTs exist
as dimers with a subunit molecular mass of 23^25 kDa and
have been grouped into at least seven distinct classes, namely
alpha, mu, pi, theta, sigma, kappa and zeta on the basis of
immunological properties and primary structure [1^3,10,11].
GST isoenzymes belonging to the same class show greater
than 60% sequence identity in their primary structure, whereas
GSTs belonging to di¡erent classes have less than 30% se-
quence identity [2]. However, despite their low inter-class se-
quence identity, crystallographic studies have indicated that
the overall polypeptide fold of the di¡erent GSTs are very
similar [3,12^15].
In our laboratories, a GST isoenzyme, originally named
Pm-GST-6.0, was puri¢ed and characterised from the Gram-
negative bacterium Proteus mirabilis [4]. Its sequence was ¢rst
resolved at the protein level [16], but the corresponding gene
sequence is now available [17]. We found that P. mirabilis
GST was predominantly located in the periplasmic space,
supporting its suggested role in cellular detoxi¢cation [18].
Recently, its three-dimensional crystal structure has also
been resolved [19]. This enzyme exhibits several kinetic, struc-
tural and immunological characteristics that distinguish it
from GSTs of other classes. For example, it does not appear
to utilise either a Tyr, Ser or Cys residue to activate gluta-
thione and it was subsequently found to have a molecule of
GSH covalently bound to a cysteine residue at position 10 of
the enzyme [19,20]. Because of its peculiar structural and im-
munological properties, P. mirabilis GST has been identi¢ed
as the prototype of a new GST class i.e. ‘beta class’ and
following the guidelines adopted for mammalian GSTs, it is
now referred to as PmGST B1-1 [19].
Comparing the amino acid sequence of PmGST B1-1 with
the sequences of the GSTs from other classes present in the
Swiss-Prot protein sequence data bank, it appears that only
two residues, namely Pro-53 and Asp-155, are strictly con-
served. These residues thus become obvious candidates for
playing crucial structural and/or catalytic roles in this class
of enzymes. A recent study has shown that the aspartic acid
residue belongs to a local conserved motif ‘Ser/Thr-Xaa-Xaa-
Asp’ which may have a role in the folding of the protein [21].
Pro-53 adopts a cis con¢guration in all known GST structures
[12,15] and is also present in homologous structures from the
thioredoxin superfamily from which GSTs are thought to
have evolved [19]. Pro-53 is located in a L-turn that lines
the base of the GSH binding site (G-site) and is thought
important for the proper folding and maintenance of the G-
site. Most importantly, the cis-proline ensures that the main-
chain atoms of the proceeding residue in the sequence are able
to form an anti-parallel L-sheet interaction with the main-
chain atoms of the cysteinyl moiety of the substrate [12,15].
Given the importance of this residue it is surprising that there
are no experimental data con¢rming the role of this residue in
any GST to date. In order to evaluate the role of Pro-53 in
PmGST B1-1, this residue was replaced with Ser by site-di-
rected mutagenesis and the e¡ect of the replacement on the
activity, thermal stability and antibiotic binding capacity of
the enzyme was examined.
2. Materials and methods
2.1. Chemicals
Isopropyl-L-D-thiogalactopyranoside (IPTG), guanidinium chloride
(GdmCl), as well as antibiotics used in the present work were pur-
chased from Sigma-Aldrich (Milan, Italy). All other reagents used
were of the highest grade commercially available.
2.2. Multiple sequence alignment
GST sequences were taken from the Swiss-Prot protein sequence
data bank. The multiple sequence alignment was obtained by Clus-
talW [22] at Network Protein Sequence Analysis, IBCP, France.
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2.3. Oligonucleotide-directed mutagenesis
The DNA encoding PmGST B1-1 in pBtac1 (pGPT1) [17] was used
as a template in the mutagenesis procedure. The single mutation P53S
was made with the following oligonucleotide: 5P-C TAA TTG AAG
AAC CGA AAC TTG CCC-3P. The oligonucleotide-directed USE
mutagenesis kit (Pharmacia Biotech) was used according to the man-
ufacturer’s instructions. Clones with the required mutation were ¢rst
identi¢ed by colony hybridisation, using 5P-32P-labelled mutameric
oligonucleotides as probes, and con¢rmed by dideoxynucleotide se-
quencing [23].
2.4. Expression and puri¢cation of mutant and wild type PmGST B1-1
enzymes
To induce the mutant and wild type gene transcription, IPTG was
added to a ¢nal concentration of 1 mM when Escherichia coli XL1-
Blue strains, grown at 37‡C in a Luria-Bertani (LB) medium [24]
supplemented with tetracycline and ampicillin, reached an approxi-
mate A550 of 0.4, and the incubation was prolonged for a further 16 h.
The puri¢cation of mutant and wild type enzymes was performed as
reported by Di Ilio et al. [4]. Brie£y, the bacterial cells were collected
by centrifugation, washed twice and resuspended in 10 mM potassium
phosphate bu¡er, pH 7.0, containing 1 mM EDTA (bu¡er A) and
disrupted by cold sonication. The particulate material was removed by
centrifugation and the resulting supernatants were applied to a GSH-
Sepharose a⁄nity column [25]. The column was exhaustively washed
with bu¡er A, supplemented with 50 mM KCl. The enzyme was
eluted with Tris-HCl bu¡er pH 9.6 containing 10 mM GSH. The
fractions containing GST activity were pooled, concentrated by ultra-
¢ltration, dialysed against bu¡er A and subjected to further analyses.
SDS-PAGE in discontinuous slab gel was performed by the method of
Laemmli [26]. Protein concentration was determined by the method of
Bradford [27] with Q-globulin as standard.
2.5. Enzyme assays
GST activity towards 1-chloro-2,4-dinitrobenzene (CDNB) was as-
sayed at 30‡C according to the method of Habig and Jakoby [28]. For
the enzyme kinetic determinations either CDNB or GSH was held
constant at 1 mM and 5 mM respectively, whilst the concentration
of the other substrate was varied, (0.1^5 mM for GSH, and 0.1^
1.6 mM for CDNB). The selenium-independent glutathione peroxi-
dase activity of GST was measured with cumene hydroperoxide
(Cu-OOH) as previously described [29]. For the enzyme kinetic deter-
minations either Cu-OOH or GSH was held constant at 0.8 mM and
1.3 mM respectively, whilst the concentration of the other substrate
was varied (0.1^3 mM for GSH, and 0.05^1.5 mM for Cu-OOH). For
both types of assay, the initial velocity was measured at least in
triplicate. Fitting was carried out using the computer program ENZ-
FITTER based on an iterative Gauss-Newton procedure [30]. The
data ¢tted well to the equation for a rectangular hyperbola.
To study unfolding, PmGST B1-1 and the P53S mutant (7 WM)
were ¢rst incubated for 30 min at 25‡C in 0.2 M potassium phosphate
bu¡er, pH 6.5, containing 1 mM EDTA with 0^4 M GdmCl. At the
end of incubation, each sample was assayed for remaining GST ac-
tivity in 1 ml of ¢nal volume but including the same concentration of
GdmCl as used in the incubation. In the refolding studies, denatured
protein was rapidly diluted (1:50) in the same bu¡er and the activity
measured after 10 min. Thermal stability measurements of native and
mutant enzymes (0.7 WM) were carried out by incubating the samples
at each temperature for 15 min. GST activity was determined at the
end of incubation.
2.6. Fluorescence measurements
The intrinsic £uorescence spectra of the protein were recorded on a
Spex spectro£uorometer (model Fluoromax) equipped with a thermo-
statically controlled sample holder at 25‡C. Emission spectra (excita-
tion at 280 nm) were recorded in 1 nm wavelength increments, and the
signal was acquired for 1 s at each wavelength. Spectra were corrected
by subtraction of the corresponding spectra for blank samples.
2.7. Growth curve
A single colony of E. coli XL1Blue (pGPT1) was inoculated with
LB medium [24] and growth overnight in a water bath shaker. 150 ml
of LB medium containing 3 ml of overnight culture and 1 mM IPTG
was incubated at 37‡C in a water bath shaker, monitoring the absorb-
ance at 600 nm. When a 0.250 value in absorbance was reached, the
cells were exposed to 1/8 and 1/2UMIC of rifamycin (MIC = 50 Wg/
ml). A sample without IPTG was used as control. MIC was deter-
mined by a standard broth microdilution technique [31].
3. Results and discussion
Puri¢cation of the recombinant enzyme was based on a⁄n-
ity chromatography on GSH-Sepharose and was carried out
as previously described [4]. A ¢nal yield of about 9 mg was
obtained from 1 l of culture. Judging from the results of the
puri¢cation it appears that the binding of enzyme to the
GSH-a⁄nity matrix was not altered noticeably by the muta-
tion, suggesting that the binding of the ligand was largely
una¡ected. The electrophoretic mobility and the immunolog-
ical reactivity of the mutated enzyme were indistinguishable
from those of the wild type enzyme (data not shown). The
puri¢ed recombinant enzyme was not very stable in 10 mM
potassium phosphate bu¡er pH 7.0 containing 1 mM EDTA
at 25‡C. The addition of glycerol to a ¢nal concentration of
10% helped to stabilise the enzyme at 320‡C. In this condi-
tion the enzyme retains 100% activity for at least 3 months.
The speci¢c activities of the mutant enzyme compared to
the wild type enzyme, measured with both CDNB and Cu-
OOH as substrates, are presented in Tables 1 and 2. The
results indicate that the speci¢c activities of the mutant en-
zyme toward CDNB and Cu-OOH were about 6% and 10% of
that of the wild type, respectively. Tables 1 and 2 also show
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Table 1
Speci¢c activity and kinetic constants for PmGST B1-1 and P53S mutant with CDNB as second substrate
Enzyme Speci¢c activity (Wmol min31 mg31) GSH CDNB
Km
(WM)
Kcat
(min31)
Kcat/Km
(WM31 min31)
Km
(WM)
Kcat
(min31)
Kcat/Km
(WM31 min31)
PmGST B1-1 1.1 686 58.1 84 730 69.3 95
P53S 0.062 1337 2.5 1.87 1346 5.64 4.19
Table 2
Speci¢c activity and kinetic constants for PmGST B1-1 and P53S mutant with cumene hydroperoxide (Cu-OOH) as second substrate
Enzyme Speci¢c activity (Wmol min31 mg31) GSH Cu-OOH
Km
(WM)
Kcat
(min31)
Kcat/Km
(WM31 min31)
Km
(WM)
Kcat
(min31)
Kcat/Km
(WM31 min31)
PmGST B1-1 0.23 691 15.2 22 3359 34.8 10.4
P53S 0.024 674 2.3 3.4 9284 12.7 1.4
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the kinetic parameters obtained by using CDNB and Cu-
OOH as co-substrate with GSH. The catalytic e⁄ciency of
the mutant enzyme toward GST substrates was found to be
signi¢cantly lower than that of the wild type. This reduction is
caused mainly by a much lower Kcat and a slightly higher Km
value than that of the wild type enzyme. Thus, the a⁄nity for
GSH of the enzyme was not signi¢cantly altered by the re-
placement of Pro-53 with Ser. This is not surprising since
GSH is bound to the enzyme through multiple interactions
including three salt bridges, eight polar interactions and nine
van der Waals interactions [19]. The loss of up to two polar
interactions from Val-52, the residue proceeding the cis-pro-
line, would be predicted to have a marginal e¡ect on the
a⁄nity of the enzyme for GSH.
The £uorescence spectra of the wild type and mutant en-
zyme, in the presence and absence of 2 mM GSH, are shown
in Fig. 1. The overall spectra are very similar, i.e. the same
excitation wavelength at 280 nm and emission maxima at 339
nm. However, there was a signi¢cant increase in £uorescence
intensity with the mutant enzyme indicating that the replace-
ment of Pro-53 with Ser results in a change in protein con-
formation. Fig. 2 shows the unfolding/refolding transition
curves of both wild type and mutant enzymes induced by
GdmCl. It can be seen that the curves of wild type and mu-
tant are coincident with each other (within experimental error)
suggesting that the substitution of Pro-53 with Ser changes
neither the overall stability of the protein nor the unfolding/
refolding kinetics of the protein. Fig. 3 shows the enzyme
activity remaining for both wild type and mutant after their
incubation in 10 mM potassium phosphate bu¡er pH 7.0 at
various temperatures for 15 min, in the presence and absence
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Fig. 1. Fluorescent emission spectra of wild type and the Pro-53-Ser
mutant, in the present and absence of 2 mM GSH.
Fig. 2. Unfolding/refolding transition curves of wild type (a/b) and
Pro-53-Ser (O/R) mutant induced by GdmCl, monitored by
changes in enzyme activity.
Fig. 3. E¡ect of temperature on the stability of wild type (a,b) and
Pro-53-Ser mutant (O,R) in the presence (closed symbols) and ab-
sence (open symbols) of 2 mM GSH. The enzymatic activity at
25‡C was taken as 100%.
Fig. 4. E¡ect of rifamycin on the growth rate of cells over-express-
ing wild type and the Pro-53-Ser mutant. b, 1/2UMIC value plus
IPTG; c, 1/2UMIC value without IPTG; O, 1/8UMIC value plus
IPTG; R, 1/8UMIC value without IPTG. MIC value is 50 Wg/ml
for rifamycin.
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of 2 mM GSH. The data presented demonstrate that the mu-
tant enzyme is more easily inactivated by heat treatment than
wild type. In fact, the wild-type enzyme retains more than
80% of its activity after 15 min incubation at 70‡C, whereas
the mutant enzyme after an identical treatment retains only
5% of its activity. No protective e¡ect on heat inactivation
was obtained in the presence of GSH. These results strongly
suggest that Pro-53 might be critical in maintaining the proper
conformation of the enzyme.
We have previously demonstrated that PmGST B1-1 is able
to bind avidly, in vivo, to di¡erent classes of antibiotics, in-
cluding rifamycin, suggesting a possible role for the bacterial
enzyme in antibiotic resistance [17]. To date, no crystals of
PmGST B1-1 complexed with rifamycin have been success-
fully grown and as a consequence the identity of the amino
acid residues contacting the drugs are unknown. On the basis
of the wild type structure it has suggested that a hydrophobic
cavity located at the dimer interface may be involved in bind-
ing drugs [19].
To examine the possible involvement of Pro-53 in antibiotic
binding, the growth rate of Pro-53-Ser mutant-overexpressed
cells in the presence of di¡erent concentrations of rifamycin
was measured and compared with cells overexpressed for wild
type. For comparison, the same experiment with cells not
overexpressing for mutant and wild type enzymes has been
carried out.
As can be seen in Fig. 4, rifamycin di¡erentially a¡ected the
growth rate of cells overexpressed for Pro-53-Ser mutant and
wild type. In fact, in the presence of 6.25 and 25 Wg/ml rifa-
mycin, the cells overexpressing wild type protein continued to
grow, whereas the growth of cells overexpressing Pro-53-Ser
mutant was substantially inhibited.
These results suggest that Pro-53 may play a role in the
direct binding of antibiotics. Pro-53 is located at the base of
the G-site, positioned adjacent to both the H-site (the binding
site for hydrophobic electrophiles) and the dimer interface.
Previous studies of PmGST B1-1 by £uorescence spectroscopy
have suggested that the antibiotic binding site is close to a
tryptophan residue [5]. The two most likely sites, based on this
and the crystallography data [19], are either in the H-site or in
the dimer interface. However, antibiotics bind to the enzyme
in a non-competitive manner with respect to GSH or CDNB,
ruling out the G- and H-sites as possible locations of the
antibiotic binding site. Thus we hypothesise that the replace-
ment of Pro-53 with Ser causes conformational changes at the
dimer interface which in turn a¡ect antibiotic binding. Such
changes are in accord with the £uorescence results reported
here which suggest localised conformational changes (Fig. 1).
In conclusion, the results of our experiments suggest that
Pro-53, even though located in a L-turn that lines the G-site,
is not a major contributor to GSH binding nor is it directly
involved in catalytic reaction. The mutation of Pro-53 does
not cause any large scale conformational changes to the en-
zyme as judged by the electrophoresis, antibody, £uorescence
and unfolding data. However, small, localised changes are
evidenced by the £uorescence and antibiotic binding data.
The heat lability data indicate that Pro-53 is important for
stabilising the normal conformation of the enzyme’s active site
since the active site structure of the mutant is more readily
damaged at high temperatures. Finally, Pro-53 appears to be
an important determinant of antibiotic binding.
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